A potential link between fibroblast growth factor-23 and the progression of AKI to CKD

Abstract Background Patients who recover from acute kidney injury (AKI) have a 25% increase in the risk of chronic kidney disease (CKD) and a 50% increase in mortality after a follow-up of approximately 10 years. Circulating FGF-23 increases significantly early in the development of AKI, is signific...

Full description

Bibliographic Details
Main Authors: Yinghui Lu, Shutian Xu, Rong Tang, Cui Han, Chunxia Zheng
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-023-03125-1
_version_ 1797850183206174720
author Yinghui Lu
Shutian Xu
Rong Tang
Cui Han
Chunxia Zheng
author_facet Yinghui Lu
Shutian Xu
Rong Tang
Cui Han
Chunxia Zheng
author_sort Yinghui Lu
collection DOAJ
description Abstract Background Patients who recover from acute kidney injury (AKI) have a 25% increase in the risk of chronic kidney disease (CKD) and a 50% increase in mortality after a follow-up of approximately 10 years. Circulating FGF-23 increases significantly early in the development of AKI, is significantly elevated in patients with CKD and has become a major biomarker of poor clinical prognosis in CKD. However, the potential link between fibroblast growth factor-23 levels and the progression of AKI to CKD remains unclear. Method Serum FGF-23 levels in AKI patients and ischaemia‒reperfusion injury (IRI) mice were detected with ELISA. Cultured HK2 cells were incubated with FGF-23 and PD173074, a blocker of FGFR, and then TGFβ/Smad and Wnt/β-catenin were examined with immunofluorescence and immunoblotting. Quantitative real-time polymerase chain reaction was used to detect the expression of COL1A1 and COL4A1. Histologic staining confirmed renal fibrosis. Results The level of serum FGF-23 was significantly different between AKI patients and healthy controls (P < 0.01). Moreover, serum FGF-23 levels in the CKD progression group were significantly higher than those in the non-CKD progression group of AKI patients (P < 0.01). In the AKI-CKD mouse model, serum FGF-23 levels were increased, and renal fibrosis occurred; moreover, the protein expression of β-catenin and p-Smad3 was upregulated. PD173074 downregulated the expression of β-catenin and p-Smad3 and reduced fibrosis in both mice and HK2 cells. Conclusion The increase in FGF-23 may be associated with the progression of AKI to CKD and may mediate renal fibrosis via TGF-β and Wnt/β-catenin activation.
first_indexed 2024-04-09T18:56:18Z
format Article
id doaj.art-af6f0d39ea124d40bc6144edf361562a
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-04-09T18:56:18Z
publishDate 2023-04-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-af6f0d39ea124d40bc6144edf361562a2023-04-09T11:10:31ZengBMCBMC Nephrology1471-23692023-04-012411710.1186/s12882-023-03125-1A potential link between fibroblast growth factor-23 and the progression of AKI to CKDYinghui Lu0Shutian Xu1Rong Tang2Cui Han3Chunxia Zheng4Jinling Hospital, National Clinical Research Center of Kidney Diseases, Nanjing University School of MedicineJinling Hospital, National Clinical Research Center of Kidney Diseases, Nanjing University School of MedicineJinling Hospital, National Clinical Research Center of Kidney Diseases, Nanjing University School of MedicineJinling Hospital, National Clinical Research Center of Kidney Diseases, Nanjing University School of MedicineJinling Hospital, National Clinical Research Center of Kidney Diseases, Nanjing University School of MedicineAbstract Background Patients who recover from acute kidney injury (AKI) have a 25% increase in the risk of chronic kidney disease (CKD) and a 50% increase in mortality after a follow-up of approximately 10 years. Circulating FGF-23 increases significantly early in the development of AKI, is significantly elevated in patients with CKD and has become a major biomarker of poor clinical prognosis in CKD. However, the potential link between fibroblast growth factor-23 levels and the progression of AKI to CKD remains unclear. Method Serum FGF-23 levels in AKI patients and ischaemia‒reperfusion injury (IRI) mice were detected with ELISA. Cultured HK2 cells were incubated with FGF-23 and PD173074, a blocker of FGFR, and then TGFβ/Smad and Wnt/β-catenin were examined with immunofluorescence and immunoblotting. Quantitative real-time polymerase chain reaction was used to detect the expression of COL1A1 and COL4A1. Histologic staining confirmed renal fibrosis. Results The level of serum FGF-23 was significantly different between AKI patients and healthy controls (P < 0.01). Moreover, serum FGF-23 levels in the CKD progression group were significantly higher than those in the non-CKD progression group of AKI patients (P < 0.01). In the AKI-CKD mouse model, serum FGF-23 levels were increased, and renal fibrosis occurred; moreover, the protein expression of β-catenin and p-Smad3 was upregulated. PD173074 downregulated the expression of β-catenin and p-Smad3 and reduced fibrosis in both mice and HK2 cells. Conclusion The increase in FGF-23 may be associated with the progression of AKI to CKD and may mediate renal fibrosis via TGF-β and Wnt/β-catenin activation.https://doi.org/10.1186/s12882-023-03125-1AKI – CKDRenal fibrosisFGF-23
spellingShingle Yinghui Lu
Shutian Xu
Rong Tang
Cui Han
Chunxia Zheng
A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
BMC Nephrology
AKI – CKD
Renal fibrosis
FGF-23
title A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
title_full A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
title_fullStr A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
title_full_unstemmed A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
title_short A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
title_sort potential link between fibroblast growth factor 23 and the progression of aki to ckd
topic AKI – CKD
Renal fibrosis
FGF-23
url https://doi.org/10.1186/s12882-023-03125-1
work_keys_str_mv AT yinghuilu apotentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT shutianxu apotentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT rongtang apotentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT cuihan apotentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT chunxiazheng apotentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT yinghuilu potentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT shutianxu potentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT rongtang potentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT cuihan potentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd
AT chunxiazheng potentiallinkbetweenfibroblastgrowthfactor23andtheprogressionofakitockd